Q3 2024 Surgery Partners Inc Earnings Call Transcript
Key Points
- Surgery Partners Inc (SGRY) reported a net revenue of $770 million for the third quarter, representing a growth of over 14% compared to the previous year.
- Adjusted EBITDA grew by 22% to $128.6 million, with margins expanding by 100 basis points to 16.7%.
- The company experienced a significant increase in total joint replacements in their ASCs, with a 53% growth in the quarter.
- Surgery Partners Inc (SGRY) successfully completed acquisitions in high-growth markets, including two multi-specialty orthopedic ASCs in Chicago.
- The company recruited over 230 new physicians in the third quarter, focusing on high acuity areas such as orthopedics, spine, and cardiology.
- Hurricane Helene and Hurricane Milton impacted several facilities, causing scheduling disruptions and some facility damage.
- Operating cash flows were affected by the timing of routine transactions and marginal impacts from the hurricanes.
- The company has a high level of corporate debt, totaling $2.2 billion, although there are no maturities until 2030.
- There was a decrease in operating cash flow compared to the previous year, attributed to increased transaction-related costs.
- The company noted challenges in the payer dynamics, although the impact was muted due to the nature of their business.
Greetings, and welcome to the Surgery Partners third quarter 2024 earnings call. (Operator Instructions) As a reminder, this conference is being recorded. At this time, I would like to turn the call over to Dave Doherty. Please go ahead.
Good morning. My name is Dave Doherty, CFO of Surgery Partners. I'm joined today by Eric Evans, our CEO; and Wayne DeVeydt, our Executive Chairman. During this call, we will make forward-looking statements. There are risk factors that could cause future results to be materially different from these statements. These risk factors are described in this morning's press release and the reports we file with the SEC, each of which are available on our website, surgerypartners.com. The company does not undertake any duty to update these forward-looking statements.
In addition, we will reference certain financial measures that are considered non-GAAP, which we believe can be useful in evaluating our performance. The presentation of this
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
